2.03
Seer Inc stock is traded at $2.03, with a volume of 147.37K.
It is down -0.49% in the last 24 hours and up +6.84% over the past month.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
See More
Previous Close:
$2.04
Open:
$2.03
24h Volume:
147.37K
Relative Volume:
0.70
Market Cap:
$112.41M
Revenue:
$15.04M
Net Income/Loss:
$-70.49M
P/E Ratio:
-1.6313
EPS:
-1.2444
Net Cash Flow:
$-49.88M
1W Performance:
-7.31%
1M Performance:
+6.84%
6M Performance:
-0.98%
1Y Performance:
-8.14%
Seer Inc Stock (SEER) Company Profile
Name
Seer Inc
Sector
Industry
Phone
650-453-0000
Address
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Compare SEER vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SEER
Seer Inc
|
2.03 | 112.41M | 15.04M | -70.49M | -49.88M | -1.2444 |
|
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
|
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-04-26 | Initiated | Canaccord Genuity | Buy |
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Aug-11-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Dec-29-20 | Initiated | BofA Securities | Neutral |
| Dec-29-20 | Initiated | Cowen | Outperform |
| Dec-29-20 | Initiated | JP Morgan | Overweight |
| Dec-29-20 | Initiated | Morgan Stanley | Equal-Weight |
View All
Seer Inc Stock (SEER) Latest News
Major backer lines up $2.5M for Senti Biosciences (NASDAQ: SNTI) if merger closes - Stock Titan
Radoff-JEC Group Calls on Meeta Gulyani to Immediately Resign from Seer, Inc.'s Board of Directors - marketscreener.com
Seer Stock Price Forecast. Should You Buy SEER? - StockInvest.us
Seer stock trades near net cash as activist pressure mounts - ad-hoc-news.de
SEER Looks 5.8% Undervalued on GF Value™ - GuruFocus
Radoff-JEC Group Calls on Meeta Gulyani to Immediately Resign from Seer, Inc.’s Board of Directors - Stock Titan
Seer Inc (SEER) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Seer president & CFO David Horn sells $14,809 of stock - Investing.com
Seer (SEER) Earnings Update: EPS Misses Its Estimate in Latest Trading; Price Reaction - vinanet.vn
Seer (SEER) Results at a Glance: Profit Per Share Falls Below Its Benchmark in the Latest Session; Price Reaction: Shares Move Higher 1.49%Final Results - vinanet.vn
Seer president & CFO David Horn sells $14,809 in company stock - Investing.com
Seer president & CFO David Horn sells $14,809 in company stock - Investing.com Nigeria
Seer president & CFO David Horn sells $14,809 in company stock - Investing.com UK
Seer president & CFO David Horn sells $14,809 in company stock - Investing.com
Insider Selling: Seer (NASDAQ:SEER) CFO Sells $14,837.27 in Stock - MarketBeat
Seer president & CFO David Horn sells $14,809 in company stock - Investing.com Canada
Seer (SEER) Q2 2026 Earnings Call Transcript - The Globe and Mail
SEER Q2 2026 Earnings: Wider-than-Expected Loss Reflects Continued Proteomics Platform InvestmentROIC Trend Report - Vinanet
SEER Looks 2.5% Overvalued on GF Value™ as Acquisition Talks Hea - GuruFocus
Radoff-JEC Group Calls on Seer, Inc.'s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers - Investing News Network
Seer Stockholders Radoff, Torok Urge Board to Disclose Timeline for Evaluating Takeover Bids - marketscreener.com
Radoff-JEC Group Calls on Seer, Inc.’s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers - Stock Titan
CCORF Maintains Seer Inc(SEER.US) With Buy Rating, Maintains Target Price $4 - moomoo.com
Seer, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Seer Q2 2026 slides show validation momentum despite revenue miss By Investing.com - Investing.com Canada
Seer, Inc. (SEER) stock price, news, quote and history - Yahoo Finance Singapore
Seer, Inc. (SEER) stock price, news, quote and history - Yahoo Finance UK
Earnings Preview: Seer Inc to Report Financial Results on August 11 - 富途牛牛
Seer Inc (SEER) (Q2 2026) Earnings Call Highlights: Navigating Funding Headwinds While ... By GuruFocus - Investing.com Canada
Seer Inc (SEER) (Q2 2026) Earnings Call Highlights: Navigating F - GuruFocus
Seer Q2 2026 Earnings Call Transcript - MarketBeat
Seer receives dual acquisition bids from Radoff-JEC Group and CEO Farokhzad - scanx.trade
Seer Q2 2026 slides: scientific gains contrast revenue decline By Investing.com - Investing.com India
Seer Inc Q2 Results: Company to Report Financials on Aug 11 - scanx.trade
Schall Law Firm investigates Seer, Inc. for securities law violations - scanx.trade
Seer Q2 Earnings Call Highlights - MarketBeat
Seer Q2 Earnings Call Highlights - TradingView
Earnings Preview: Seer Inc to Report Financial Results on August 11 - Moomoo
SEER Looks 3.1% Undervalued on GF Value™ at $2.16 - GuruFocus
Seer, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:SEER) 2026-08-11 - Seeking Alpha
Earnings call transcript: Seer misses Q2 2026 estimates as shares slip after hours - Investing.com South Africa
SEER: Sequential revenue growth, robust scientific validation, and strong cash position support outlook - TradingView
Earnings call transcript: Seer misses Q2 2026 estimates as shares slip after hours - Investing.com
Seer Q2 2026 slides: scientific gains contrast revenue decline - Investing.com
Seer Q2 EPS $(0.31) misses estimate, revenue falls 24% - scanx.trade
SEER: Q2 revenue rose sequentially to $3.1M, with reaffirmed 2026 guidance and strong scientific momentum - TradingView
Is Seer Inc (SEER) Undervalued After Q2 Earnings Miss? Revenue a - GuruFocus
Seer, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Seer, Inc. 2Q 2026: Revenue $3.1M, Net loss $(16.90M), EPS $(0.31) — 10-Q Summary - TradingView
Seer (NASDAQ:SEER) Issues Quarterly Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat
Seer Inc Stock (SEER) Financials Data
Revenue
Net Income
Cash Flow
EPS
Seer Inc Stock (SEER) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Nishar Dipchand | Director |
Jul 08 '26 |
Sale |
2.18 |
10,660 |
23,265 |
59,044 |
| DIPCHAND NISHAR | Director |
Jul 08 '26 |
Proposed Sale |
2.18 |
10,660 |
23,265 |
0 |
| Horn David R. | PRESIDENT & CFO |
May 20 '26 |
Sale |
1.69 |
7,303 |
12,352 |
493,959 |
| Farokhzad Omid | CEO AND CHAIR |
Feb 18 '26 |
Sale |
1.99 |
24,385 |
48,646 |
3,349,064 |
| Horn David R. | PRESIDENT & CFO |
Feb 18 '26 |
Sale |
1.99 |
7,743 |
15,447 |
501,262 |
| Horn David R. | PRESIDENT & CFO |
Nov 19 '25 |
Sale |
1.97 |
6,797 |
13,400 |
436,802 |
| Farokhzad Omid | CEO AND CHAIR |
Nov 19 '25 |
Sale |
1.97 |
33,838 |
66,708 |
1,238,230 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):